Fundraising FoxSeae Ventures — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
KIYATEC develops 3D Predict, a tumor-specific testing platform that uses patient-derived tumor cells to predict how individual cancers respond to therapies.
BiotechDigital HealthHealthtechMedical DevicesGreenville, US
Matthew Gevaert(Director)Eric Perreault(Executive Officer, Director)inMelissa Rayner(Executive Officer)inScott Isacksen(Executive Officer)inDavid E Orr(Chief Operating Officer)in
BoardChristopher Brotherton(Director)
Board seatJason Robart· per SEC Form D
Co-investorsAtlanta Technology AngelsVentureSouth
Movn Health is a healthcare company focused on improving access to cardiovascular care, working to improve health outcomes, care coordination, patient engagement, and retention.
Digital HealthHealthtechLos Angeles, US
Harshvardhan Vathsangam(Executive Officer, Director)Ade Adesanya(Co-Founder, President)inGaurav Sukhatme(Co-Founder)inHarsh Vathsangam, PhD(Co-Founder, CEO)inShuo Qiao(Co-Founder, Chief Technology & Compliance Officer)in
BoardBob Saunders(Director)in
Board seatJason Robart· per SEC Form D
Co-investorsAlmond Tree CapitalAphelion CapitalFoothill VenturesGaingelsSolve VenturesSteelSky Ventures+6 more
__Twitter.png)
Violet provides healthcare organizations with data analytics and tools to measure and improve their ability to deliver person-centered care that considers patients' individual preferences, identities, and experiences.
Data & InfrastructureDigital HealthHealthtechNew York City, US
Gaurang Choksi(CEO and Founder)inScott Zaloom(Head of Operations)inDr. Kay Nikiforova(Head of Clinical & Research)inEliot Kristan(Head of Engineering)in
Co-investorsGaingelsHead & Heart CapitalSemperVirens Venture CapitalThe Venture CollectiveW Health Ventures Gp LlcDementia Discovery Fund+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.